Bio & Pharma
Lunit participates in Singapore's AI diagnostic solution project
The company plans to take part in NHG's chest X-ray reading workflow improvement project
By Aug 14, 2024 (Gmt+09:00)
1
Min read
Most Read
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
K-content powerhouse’s YouTube channels disrupted by hacks
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Bioscience sells stake in US vaccine developer Novavax
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Fire-plagued Mercedes uses Chinese cells for most EVs in S.Korea
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Gas maker Air Products Korea put on sale for around $3.6 bn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![Lunit participates in Singapore's AI diagnostic solution project](https://www.kedglobal.com/data/ked/image/2024/08/14/ked202408140016.600x.0.png)
Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that it solely participates in a chest X-ray reading workflow improvement project led by Singapore's National Healthcare Group (NHG).
According to Lunit, Singapore's public healthcare services are divided among three healthcare institutions, with NHG responsible for the central and northern regions of Singapore.
The purpose of this project is to verify the effectiveness of using AI in improving the chest X-ray reading process and the efficiency of medical resource allocation at NHG-affiliated medical institutions.
Lunit plans to install its chest X-ray AI image analysis solution Lunit Insight CXR at primary care institutions under NHG to enhance the efficiency of the reading system.
NHG plans to conduct the project until August next year and, if the value of AI utilization is proven, will propose to the Singaporean government to improve the image reading protocols for public hospitals.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
-
Artificial intelligenceLunit eyes developing markets with AI cancer diagnostics
Jul 09, 2024 (Gmt+09:00)
4 Min read -
Mergers & AcquisitionsLunit buys breast cancer detection AI firm Volpara Health
May 22, 2024 (Gmt+09:00)
2 Min read -
-
Artificial intelligenceLunit gets court approval for Volpara acquisition in New Zealand
Mar 14, 2024 (Gmt+09:00)
1 Min read
Comment 0
LOG IN